Jubilant Life Sciences has received USFDA approval for Indocin
Jubilant Life Sciences has received final USFDA approval for the generic version of its non-steroidal anti-inflammatory drug, Indocin. The approval for Indomethacin capsules is a […]
Jubilant Life Sciences has received final USFDA approval for the generic version of its non-steroidal anti-inflammatory drug, Indocin. The approval for Indomethacin capsules is a […]
Ajanta Pharma has launched eletriptan hydrobromide tablets in the US market. The drug is a bioequivalent generic version of Relpax tablets and the company has […]
Zydus Cadila has received final USFDA approval to market aspirin and extended release dipyridamole capsules, which is used to prevent excessive blood clotting and reduce […]
Ajanta Pharma has received final USFDA approval for Entacapone tablets to market the same in USA. It is a bioequivalent generic version of Comtan tablets. […]
Lupin has received final USFDA approval to market generic Nadolol tablets, used for treatment of hypertension, in the American market. The drug will be marketed […]
AstraZeneca Pharma has received marketing authorisation from the Drug Controller General India DCG(I) for Xigduo XR tablets used in treatment of adults with type II […]
Glenmark Pharmaceuticals has launched Apremilast, the first advanced oral systemic treatment for Psoriasis in India. The drug is phosphodiesterase 4 (PDE4) inhibitor indicated for the […]
Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now have a total of 69 […]
Copyright © 2024 | WordPress Theme by MH Themes